Alice Lau
Papers
1
Total Citations
31
H-Index
1
About
Dr. Alice Lau is a leading researcher in urologic oncology, with a primary focus on the molecular diagnostics of prostate cancer. Her most cited work, a 2010 study on the PCA3 molecular urine assay, has garnered 31 citations and fundamentally advanced the understanding of non-invasive cancer detection. In this seminal paper, Dr. Lau investigated the utility of PCA3, a non-coding mRNA overexpressed in prostate cancer, to predict adverse pathologic features. She also rigorously evaluated the impact of different collection protocols—including catheterized specimens—on test accuracy, providing critical guidance for clinical implementation. Her contributions have helped bridge the gap between molecular biology and practical patient care, offering a more precise, urine-based alternative to traditional biopsy. By demonstrating how collection methods influence diagnostic reliability, Dr. Lau has directly improved the standardization of prostate cancer screening. Her work continues to inform ongoing efforts to reduce unnecessary invasive procedures, making her a pivotal figure in the shift toward personalized, molecular-driven urologic diagnostics.
Research Focus
Key Achievements
Top Papers
- 1